Advertisement

Cytokines and Chemokines in Novel Roles: Exploring Their Potential as Predictors of Autism Spectrum Disorder

  • Mariana Graciarena
    Correspondence
    Address correspondence to Mariana Graciarena, Ph.D., Assistant Researcher at the Institute of Physiology, Molecular Biology, and Neurosciences Institute, Int. Güiraldes 2160, Ciudad Universitaria, Ciudad Autónoma de Buenos Aires, Argentina.
    Affiliations
    Department of Physiology, Molecular and Cellular Biology, Faculty of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina
    Institute of Physiology, Molecular Biology, and Neurosciences, National Council of Scientific Research, University of Buenos Aires, Buenos Aires, Argentina
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 255
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mead J.
        • Ashwood P.
        Evidence supporting an altered immune response in ASD.
        Immunol Lett. 2015; 163: 49-55
        • Heuer L.S.
        • Croen L.A.
        • Jones K.L.
        • Yoshida C.K.
        • Hansen R.L.
        • Yolken R.
        • et al.
        An exploratory examination of neonatal cytokines and chemokines as predictors of autism risk: The Early Markers for Autism study.
        Biol Psychiatry. 2019; 86: 255-264
        • Zerbo O.
        • Yoshida C.
        • Grether J.K.
        • Van de Water J.
        • Ashwood P.
        • Delorenze G.N.
        • et al.
        Neonatal cytokines and chemokines and risk of autism spectrum disorder: The Early Markers for Autism (EMA) study: A case-control study.
        J Neuroinflammation. 2014; 11: 113
        • Krakowiak P.
        • Goines P.E.
        • Tancredi D.J.
        • Ashwood P.
        • Hansen R.L.
        • Hertz-Picciotto I.
        • et al.
        Neonatal cytokine profiles associated with autism spectrum disorder.
        Biol Psychiatry. 2017; 81: 442-451
        • Abdallah M.W.
        • Larsen N.
        • Grove J.
        • Bonefeld-Jørgensen E.C.
        • Nørgaard-Pedersen B.
        • Hougaard D.M.
        • et al.
        Neonatal chemokine levels and risk of autism spectrum disorders: Findings from a Danish historic birth cohort follow-up study.
        Cytokine. 2013; 61: 370-376
        • Campbell K.
        • Carpenter K.L.
        • Hashemi J.
        • Espinosa S.
        • Marsan S.
        • Borg J.S.
        • et al.
        Computer vision analysis captures atypical attention in toddlers with autism.
        Autism. 2019; 23: 619-628
        • Ruggeri B.
        • Sarkans U.
        • Schumann G.
        • Persico A.
        Biomarkers in autism spectrum disorder: the old and the new.
        Psychopharmacology. 2014; 231: 1201-1216
        • Yockey L.J.
        • Iwasaki A.
        Interferons and proinflammatory cytokines in pregnancy and fetal development.
        Immunity. 2018; 49: 397-412
        • Smith S.E.
        • Li J.
        • Garbett K.
        • Mirnics K.
        • Patterson P.H.
        Maternal immune activation alters fetal brain development through interleukin-6.
        J Neurosci. 2007; 27: 10695-10702
        • Choi G.B.
        • Yim Y.S.
        • Wong H.
        • Kim S.
        • Kim H.
        • Kim S.V.
        • et al.
        The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring.
        Science. 2016; 351: 933-940

      Linked Article